Log in to save to my catalogue

Anticoagulants for stroke prevention in heart failure with reduced ejection fraction

Anticoagulants for stroke prevention in heart failure with reduced ejection fraction

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8766365

Anticoagulants for stroke prevention in heart failure with reduced ejection fraction

About this item

Full title

Anticoagulants for stroke prevention in heart failure with reduced ejection fraction

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Clinical research in cardiology, 2022-01, Vol.111 (1), p.1-13

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Impaired left-ventricular ejection-fraction (LV-EF) is a known risk factor for ischemic stroke and systemic embolism in patients with heart failure (HF) even in the absence of atrial fibrillation. While stroke risk is inversely correlated with LV-EF in HF patients with sinus rhythm, strategies using anticoagulation with Vitamin-K antagonists (VKA)...

Alternative Titles

Full title

Anticoagulants for stroke prevention in heart failure with reduced ejection fraction

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8766365

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8766365

Other Identifiers

ISSN

1861-0684

E-ISSN

1861-0692

DOI

10.1007/s00392-021-01930-y

How to access this item